Buy & Sell HubSpot Inc (HUBS) – HubSpot Inc Price Today
Aura AI Summary
Key Stats
- $11.29BMarket Cap
- TechnologySector
- -39.64%3M Drawdown
- $9.85BEnterprise Value
- -Dividend Yield
- 35% Buy | 65% SellTrading Activity
- 64 daysTypical Hold Time
HubSpot Inc (HUBS) is currently valued at a market capitalization of $11.29B, with an enterprise value of $9.85B. Over the past 52 weeks, HubSpot Inc has traded between a low of $179 and a high of $609.4, highlighting its annual price range. Over the past three months, HubSpot Inc has recorded a drawdown of -39.64%, reflecting recent price volatility. On average, investors hold HubSpot Inc for approximately 64 days, indicating typical investor behavior on the platform.
About HubSpot Inc
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Most Recent News
Fulcrum Therapeutics shares plunge 49.7% after halting sickle cell drug development.
Fulcrum Therapeutics' stock dropped nearly 50% in after-hours trading after the company announced it is discontinuing its lead experimental drug, pociredir, for sickle cell disease. The decision follows FDA concerns about cancer risks linked to the d...

Inventiva temporarily suspends its stock trading on Euronext Paris ahead of a financing operation.
Inventiva, a clinical-stage biopharmaceutical company, has temporarily suspended trading of its ordinary shares on Euronext Paris starting June 2, 2026, at 9:00 CEST. This suspension is at the company's request and precedes a planned financing operat...

Inventiva halts trading on Euronext Paris ahead of new financing announcement
Inventiva, a clinical-stage biopharmaceutical company, has temporarily halted trading of its ordinary shares on Euronext Paris starting June 2, 2026, at 9:00 a.m. CEST. This pause is at the company's request and precedes a proposed financing transact...
